Previous 10 | Next 10 |
A look at the top 10 most actives in Canada iShares S&P/TSX 60 Index ETF (XIU) rose 0.2% to $34.19 on volume of 5,065,984 shares Lomiko Metals Inc. (LMR) rose 0.0% to $0.035 on volume of 3,159,378 shares Guanajuato Silver Company Ltd. (GSVR) rose 12.8% to $0.265 on volume of 2,856,082...
2024-05-21 09:21:57 ET More on Eli Lilly, Novo Nordisk Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Eli Lilly inks radiopharma deal wort...
2024-05-21 09:13:41 ET More on Eli Lilly Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Eli Lilly: Don't Overpay For Miracle Drugs Eli Lilly’s tirzepatide cleared for diabetes t...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure PR Newswire Nearly one-half of patients on mirikizumab achieved endoscopic response at 52 weeks; most...
2024-05-21 06:43:02 ET Eli Lilly ( NYSE: LLY ) has secured China approval for its blockbuster drug tirzepatide for use in treating diabetes.... Read the full article on Seeking Alpha For further details see: Eli Lilly’s tirzepatide cleared for diabetes treatme...
2024-05-20 14:06:47 ET Summary Fidelity Low Volatility Factor ETF is invested in 125 stocks with relatively low historical volatility of prices and earnings. Since its inception, the FDLO ETF has lagged the S&P 500 index, but outperformed other low-volatility ETFs. FDLO ri...
2024-05-20 10:15:35 ET More on Hims & Hers Health 10 Solid Reasons To Buy Hims & Hers Stock Hims & Hers: Strong Operating Leverage And Profitability Inflection Hims & Hers: The Growth Story, Coupled With Expanding Profitability, Promises Exponential G...
2024-05-20 10:11:34 ET More on Hims & Hers Health 10 Solid Reasons To Buy Hims & Hers Stock Hims & Hers: Strong Operating Leverage And Profitability Inflection Hims & Hers: The Growth Story, Coupled With Expanding Profitability, Promises Exponential G...
2024-05-19 15:05:03 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Biopharma M&A surges year ...
2024-05-19 06:15:00 ET Eli Lilly (NYSE: LLY) sells a broad portfolio of products, but two in particular have helped revenue growth explode in recent times. I'm talking about Lilly drugs that doctors prescribe for weight loss: Mounjaro and Zepbound. They're both based on the same mol...
News, Short Squeeze, Breakout and More Instantly...
Lilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement PR Newswire INDIANAPOLIS , July 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2024 financial results on Aug. 8, 2024 ....
2024-07-24 06:39:00 ET If you're a dividend investor, you shouldn't bother with stocks that don't raise their payouts. Inflation has drastically chipped away at consumers' purchasing power in recent years, highlighting just how important it is for dividend income to rise over the long run...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...